Subscribe to Newsletter
Subspecialties Retina

RPE Patch: What’s New?

Back in February 2019, we wrote about the use of an RPE patch to rescue retinal degeneration in animals and asked whether the research team’s success would translate to humans – well, we may now have the answer.

Since demonstrating the patch can be transplanted in animal models, the team has completed a phase I Investigational New Drug (IND) application and received FDA clearance to start a human clinical trial. “We hope our RPE-patch will be able to slow down disease progression and, if performed at the right time, even stop late-stage disease completely,” says Kapil Bharti, Head of the NEI Unit on Ocular and Stem Cell Translational Research, who led the study.

Results are expected 2-3 years from now. After this, the focus will be on making the technology accessible to those patients who could benefit. But the team also plans to develop more complex eye tissue patches – including an RPE/choroid patch and an RPE/photoreceptor patch.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. R Sharma et al., Annu Rev Pharmacol Toxicol, 60, 553 (2020). PMID: 31914900.
About the Author
Lauren Robertson

Deputy Editor at The Ophthalmologist.

Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: